Editor's view: 29 July 2010
Like Paris in the spring, the lure of the Ucits space is proving a heady experience for many managers. First Europe fell for the charms of these onshore products, now the Americans are joining in a communal swoon.
17/02/2010
Brian DeChristopher, formerly with Putnam Investments, has launched his maiden hedge fund, HFMWeek has learned.
After forming Boston-based Chordant Capital Partners, the Chordant Lifesciences Fund debuted this month. The offering is a long/short global healthcare and life sciences fund with a slight
long-bias. It has 20 long positions and 20-30 shorts. Its capacity is $500m.
DeChristopher, the fund’s portfolio manager and founder, was a healthcare analyst and portfolio manager at Putnam Investments.
Last year, the BarclayHedge healthcare and biotechnology index returned 28% and is down slightly at the start of 2010.
Stocks in the healthcare sector continue to trade at a greater discount to historical premiums. Today healthcare stocks discount to the S&P 500 is around 15% and was trading at an 11% discount
between 2005 and 2008.
The fund has a $250,000 investment minimum, 1.5/15 fees and a one-year lockup. Jefferies & Co and JP Morgan are the prime brokers.
22/09/2010
This month’s HFMWeek Subscriber Club breakfast will take place on Wednesday 22 September. Join us and…
30/09/2010
The next HFMWeek Subscriber Club breakfast will take place on Thursday 30 September. Topic and…
19/07/10
Following the success of the last year’s HFM US Hedge Fund Performance Awards we...
Be the first to comment on this article!